HUMIRA®
Solution for injection in pre-filled syringe, 40mg/0.4ml
RxActive license
Active substance (INN)
adalimumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled syringe
Strength40mg/0.4ml
PackagingUkupno 2 napunjena injekciona šprica sa po 0.4ml rastvora za injekciju u kartonskoj kutiji
ManufacturerAbbVie Biotechnology GmbH & Co. KG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AB04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJune 2, 2017
Analogs in Montenegro
7Other medicines with the same active substance
HUKYNDRARx
Solution for injection in pre-filled syringe, 40mgHUKYNDRARx
Solution for injection in pre-filled syringe, 80mgHUKYNDRARx
Solution for injection in pre-filled pen, 40mgHUMIRARx
Solution for injection in pre-filled pen, 80mgHUMIRARx
Solution for injection in pre-filled syringe, 20mg/0.2mlHYRIMOZRx
Solution for injection in pre-filled pen, 40mg/0.8mlHYRIMOZRx
Solution for injection in pre-filled syringe, 40mg/0.8mlSource: CInMED register